Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of pegylated interferon beta-1a in relapsing multiple sclerosis
NL-OMON39656Phase 3Active, not recruiting
- Sponsor
- Biogen
- Start
- Jul 2012
- Modality
- Interferons → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of interferon beta in multiple sclerosis (MS), sponsored by Biogen. Started Jul 2012; status: active, not recruiting.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON39656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39656.